n-methylaspartate has been researched along with MPTP Neurotoxicity Syndrome in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cuenca, L; Estrada, C; Gil-Martínez, AL; Gonzalez-Cuello, A; Herrero, MT; Melo-Thomas, L; Schwarting, RK | 1 |
Aggrawal, N; Agrawal, N; Ahmad, AS; Cascio, MB; Doré, S; Ehmsen, JT; Hara, MR; Hester, L; Kamiya, A; Sawa, A; Sen, N; Snyder, SH | 1 |
Burg, M; Horowski, R; Kalveram, KT; Lange, KW; Löschmann, PA; Riederer, P; Sofic, E; Wachtel, H | 1 |
Brouillet, E; Isacson, O; Penney, JB; Wüllner, U; Young, AB | 1 |
Beal, MF; Brouillet, E | 1 |
Beal, MF; Becker, DA; Klivenyi, P; MacGarvey, U; Matthews, RT; Natero, R; Wermer, M; Yang, L | 1 |
Zheng, W | 1 |
Boyce, S; Crossman, AR; Luquin, MR; Peggs, D; Sambrook, MA | 1 |
1 review(s) available for n-methylaspartate and MPTP Neurotoxicity Syndrome
Article | Year |
---|---|
Neurotoxicology of the brain barrier system: new implications.
Topics: Aluminum; Animals; Blood-Brain Barrier; Central Nervous System Diseases; Cyclosporine; Humans; Lead; Manganese Poisoning; MPTP Poisoning; N-Methylaspartate; Nitro Compounds; Nitrobenzenes; Propionates; Pyridostigmine Bromide; Xenobiotics | 2001 |
7 other study(ies) available for n-methylaspartate and MPTP Neurotoxicity Syndrome
Article | Year |
---|---|
Electrical stimulation or MK-801 in the inferior colliculus improve motor deficits in MPTP-treated mice.
Topics: Animals; Deep Brain Stimulation; Dizocilpine Maleate; Inferior Colliculi; Male; Mice; Microinjections; Motor Activity; Motor Disorders; MPTP Poisoning; N-Methylaspartate; Rotarod Performance Test | 2018 |
GOSPEL: a neuroprotective protein that binds to GAPDH upon S-nitrosylation.
Topics: 2',5'-Oligoadenylate Synthetase; Animals; Binding, Competitive; Brain; Carrier Proteins; Cells, Cultured; Disease Models, Animal; Embryo, Mammalian; Excitatory Amino Acid Agonists; Glyceraldehyde-3-Phosphate Dehydrogenases; Green Fluorescent Proteins; Humans; Mice; Mice, Knockout; Molecular Weight; MPTP Poisoning; Mutation; N-Methylaspartate; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Nitric Oxide Synthase Type I; Nuclear Proteins; Protein Binding; Protein Transport; RNA, Messenger; RNA, Small Interfering; S-Nitrosoglutathione; Transfection; Two-Hybrid System Techniques; Ubiquitin-Protein Ligases | 2009 |
The competitive NMDA antagonist CPP protects substantia nigra neurons from MPTP-induced degeneration in primates.
Topics: Animals; Behavior, Animal; Biogenic Monoamines; Callithrix; Female; Immunohistochemistry; Male; MPTP Poisoning; N-Methylaspartate; Nerve Degeneration; Neurons; Piperazines; Putamen; Receptors, N-Methyl-D-Aspartate; Substantia Nigra; Tyrosine 3-Monooxygenase | 1993 |
Glutamate receptor binding sites in MPTP-treated mice.
Topics: Animals; Autoradiography; Binding Sites; Brain; Male; Mazindol; Mice; Mice, Inbred C57BL; MPTP Poisoning; N-Methylaspartate; Receptors, Amino Acid; Receptors, AMPA; Receptors, Glutamate; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate | 1993 |
NMDA antagonists partially protect against MPTP induced neurotoxicity in mice.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Binding, Competitive; Dopamine Antagonists; Male; Mice; MPTP Poisoning; N-Methylaspartate; Nervous System | 1993 |
Azulenyl nitrone spin traps protect against MPTP neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Azulenes; Brain Chemistry; Dopamine; Free Radicals; Glutamic Acid; Male; Mice; MPTP Poisoning; N-Methylaspartate; Neuroprotective Agents; Nitrogen Oxides; Oxidation-Reduction; Sesquiterpenes; Spin Labels | 1998 |
Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey.
Topics: Animals; Aspartic Acid; Dibenzocycloheptenes; Dizocilpine Maleate; Injections, Intramuscular; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; N-Methylaspartate; Parkinson Disease, Secondary | 1989 |